Your browser doesn't support javascript.
loading
Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4+PD-1+ Cells and Inferior Survival in Patients with Newly Diagnosed Multiple Myeloma.
Alrasheed, Nouf; Lee, Lydia; Ghorani, Ehsan; Henry, Jake Y; Conde, Lucia; Chin, Melody; Galas-Filipowicz, Daria; Furness, Andrew J S; Chavda, Selina J; Richards, Huw; De-Silva, Dunnya; Cohen, Oliver C; Patel, Dominic; Brooks, Anthony; Rodriguez-Justo, Manuel; Pule, Martin; Herrero, Javier; Quezada, Sergio A; Yong, Kwee L.
Afiliación
  • Alrasheed N; Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
  • Lee L; Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
  • Ghorani E; Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
  • Henry JY; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
  • Conde L; Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
  • Chin M; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
  • Galas-Filipowicz D; Bill Lyons Informatics Centre, University College London Cancer Institute, London, United Kingdom.
  • Furness AJS; Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
  • Chavda SJ; Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
  • Richards H; Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
  • De-Silva D; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
  • Cohen OC; Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
  • Patel D; Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
  • Brooks A; Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
  • Rodriguez-Justo M; University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Pule M; Department of Histopathology, University College London, London, United Kingdom.
  • Herrero J; Institute of Child Health, University College London, London, United Kingdom.
  • Quezada SA; Department of Histopathology, University College London, London, United Kingdom.
  • Yong KL; Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
Clin Cancer Res ; 26(13): 3443-3454, 2020 07 01.
Article en En | MEDLINE | ID: mdl-32220887
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Médula Ósea / Linfocitos Infiltrantes de Tumor / Linfocitos T Reguladores / Receptor de Muerte Celular Programada 1 / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Médula Ósea / Linfocitos Infiltrantes de Tumor / Linfocitos T Reguladores / Receptor de Muerte Celular Programada 1 / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article